NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 197 filers reported holding NEVRO CORP in Q4 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,164,000 | -76.6% | 10,000 | -66.7% | 0.04% | -77.4% |
| Q2 2021 | $4,974,000 | -51.7% | 30,000 | -49.6% | 0.16% | -58.6% |
| Q4 2020 | $10,300,000 | +132.2% | 59,500 | +86.9% | 0.37% | +63.3% |
| Q3 2020 | $4,435,000 | -47.7% | 31,838 | -55.2% | 0.23% | -71.9% |
| Q2 2020 | $8,482,000 | +324.1% | 71,000 | +255.0% | 0.82% | +244.3% |
| Q1 2020 | $2,000,000 | -81.5% | 20,000 | -78.3% | 0.24% | -75.1% |
| Q4 2019 | $10,814,000 | +209.0% | 92,000 | +2.2% | 0.95% | +36.1% |
| Q4 2018 | $3,500,000 | +2.3% | 90,000 | +50.0% | 0.70% | -2.8% |
| Q3 2018 | $3,420,000 | -28.6% | 60,000 | 0.0% | 0.72% | -62.6% |
| Q2 2018 | $4,791,000 | +117.8% | 60,000 | +5.4% | 1.92% | +137.3% |
| Q4 2014 | $2,200,000 | – | 56,900 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
| Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
| TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
| Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
| Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
| Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |